Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi gets US OK for nonprescription Nasacort
Bloomberg/Businessweek
Monday, October 14, 2013 - 8:59am
tags:
Sanofi, OTC, Nasacort
Aratana Therapeutics acquires Vet Therapeutics for $30M cash, 625K shares
Yahoo/Fly on the Wall
Monday, October 14, 2013 - 8:57am
tags:
Vet Therapeutics, Aratana, M&A, animal health
Coronado's inflammatory bowel disease treatment fails mid-stage study
Reuters
Monday, October 14, 2013 - 8:54am
tags:
Coronado Biosciences, Crohn's Disease, TSO
Roche to spend $880 mln on manufacturing, create 500 jobs
Reuters
Monday, October 14, 2013 - 8:51am
tags:
Roche, drug manufacturing
Acadia And Parkinson's Treatment Hopes
Seeking Alpha
Monday, October 14, 2013 - 8:49am
tags:
Parkinson's Disease, Acadia, pimavanserin, Parkinson's Disease Psychosis
Merck KGaA seeks investors to share clinical trial costs
Yahoo/Reuters
Monday, October 14, 2013 - 8:48am
tags:
Merck KGaA, clinical trials
Johnson & Johnson Must Remedy Weak Organic Growth
TheStreet.com
Monday, October 14, 2013 - 8:47am
tags:
JNJ
China Biotech In Review: Hutchison MediPharma Partners Cancer Drug With Lilly
Seeking Alpha
Sunday, October 13, 2013 - 12:53pm
tags:
Hutchison MediPharma, Chi-Med, Aslan Pharma, Eddingpharm, Shenzhen Chipscreen Biosciences, Sihuan Pharma, China National Biotech Group
3 Humongous Health-Care Stocks This Week
Motley Fool
Sunday, October 13, 2013 - 12:08pm
tags:
TherapeuticsMD, Aratana, Cell Therapeutics
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, October 13, 2013 - 12:06pm
tags:
Ariad, Acadia, Idenix
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Pharmiweb
Saturday, October 12, 2013 - 12:02pm
tags:
Otsuka, Astex, M&A
Celtaxsys begins first clinical trial of CTX-4430 in cystic fibrosis patients
Pharmaceutical Business Review
Saturday, October 12, 2013 - 12:00pm
tags:
Celtaxsys, CTX-4430, cystic fibrosis
Will Johnson & Johnson Earnings Top Pfizer and Merck?
Motley Fool
Saturday, October 12, 2013 - 11:58am
tags:
JNJ
How the FDA Ruined Amarin's Day
Motley Fool
Saturday, October 12, 2013 - 11:56am
tags:
Amarin, FDA, Vascepa
Biogen Idec Dominant Player In Multiple Sclerosis Market
investors.com
Saturday, October 12, 2013 - 11:55am
tags:
Biogen Idec, MS, multiple sclerosis
Cramer: Bet on Johnson & Johnson (video)
The Street
Saturday, October 12, 2013 - 11:54am
tags:
JNJ
Why J&J Is Poised to Outperform
Motley Fool
Saturday, October 12, 2013 - 11:53am
tags:
JNJ
Amarin Will Receive A Positive Vote By The Advisory Committee
Seeking Alpha
Saturday, October 12, 2013 - 11:52am
tags:
Amarin
Is This Single-Drug Company Still a Good Investment?
Motley Fool
Saturday, October 12, 2013 - 10:36am
tags:
Questcor Pharmaceuticals
CytRx Announces Exercise of Underwriters’ Over-Allotment Option
Yahoo/BusinessWire
Saturday, October 12, 2013 - 10:35am
tags:
CytRx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.